ZIOPHARM Oncology Inc. (ZIOP) could find an ally in its 200-day moving average ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) is struggling today, despite a drug data win for the biotech stock. Earlier, ZIOP ...

Looking for a stock that might be in a good position to beat earnings at its next report? Consider ZIOPHARM Oncology, Inc. (ZIOP), a firm in the Biotechnology industry, which could be a great ...

If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners, an investment management firm, is bullish on ...

ZIOPHARM Oncology, Inc. 's ZIOP shares crashed 11.6% after the company announced the death of a patient in a phase I study on its lead candidate, Ad-RTS-hIL-12, for the treatment of recurrent or ...

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds’ and ...

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in NVIDIA Corp (Symbol: NVDA), where a total volume of 60,976 contracts has been ...

Ziopharm Oncology, Inc. ZIOP was a big mover last session, as the company saw its shares rise more than 6% on the day. The move came on solid volume too with far more shares changing hands than in a ...

Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors. Successful investing is a combination of fundamental analysis, technical analysis, some luck and lots of patience ...

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) is managing to hammer its shareholders in the after-hours session. The company plans to commence an underwritten public secondary offering of its common stock.

If you are looking for the best ideas for your portfolio you may want to consider some of Miller Value Partners top stock picks. Miller Value Partners, an investment management firm, is bullish on ...